Another complication of natalizumab treatment? Taking the challenge.
Norbert
N
Goebels
Ludwig
L
Kappos
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D016543:Central Nervous System Neoplasms / Q000139:chemically induced*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000139:chemically induced*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab